WHI-P258 is primarily used in biochemical and pharmacological research as a selective inhibitor of the Janus kinase 3 (JAK3) enzyme. It plays a key role in studying signaling pathways related to immune cell function, particularly in lymphocytes. Due to its specificity, it is employed to investigate conditions involving abnormal JAK-STAT signaling, such as autoimmune diseases and certain cancers. Researchers also use WHI-P258 to explore potential therapeutic strategies that modulate kinase activity without broadly suppressing the immune system. Its application remains confined to laboratory and experimental settings, mainly in cell-based assays and preclinical studies.